233 related articles for article (PubMed ID: 32493750)
1. Testis formation in XX individuals resulting from novel pathogenic variants in Wilms' tumor 1 (
Eozenou C; Gonen N; Touzon MS; Jorgensen A; Yatsenko SA; Fusee L; Kamel AK; Gellen B; Guercio G; Singh P; Witchel S; Berman AJ; Mainpal R; Totonchi M; Mohseni Meybodi A; Askari M; Merel-Chali T; Bignon-Topalovic J; Migale R; Costanzo M; Marino R; Ramirez P; Perez Garrido N; Berensztein E; Mekkawy MK; Schimenti JC; Bertalan R; Mazen I; McElreavey K; Belgorosky A; Lovell-Badge R; Rajkovic A; Bashamboo A
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13680-13688. PubMed ID: 32493750
[TBL] [Abstract][Full Text] [Related]
2. A Novel
Sirokha D; Gorodna O; Vitrenko Y; Zelinska N; Ploski R; Nef S; Jaruzelska J; Kusz-Zamelczyk K; Livshits L
Biology (Basel); 2021 Nov; 10(12):. PubMed ID: 34943163
[TBL] [Abstract][Full Text] [Related]
3. A 46,XX testicular disorder of sex development caused by a Wilms' tumour Factor-1 (WT1) pathogenic variant.
Gomes NL; de Paula LCP; Silva JM; Silva TE; Lerário AM; Nishi MY; Batista RL; Faria Júnior JAD; Moraes D; Costa EMF; Hemesath TP; Guaragna-Filho G; Leite JCL; Carvalho CG; Domenice S; Costa EC; Mendonca BB
Clin Genet; 2019 Jan; 95(1):172-176. PubMed ID: 30294972
[TBL] [Abstract][Full Text] [Related]
4. WT1 Pathogenic Variants are Associated with a Broad Spectrum of Differences in Sex Development Phenotypes and Heterogeneous Progression of Renal Disease.
Ferrari MTM; Watanabe A; da Silva TE; Gomes NL; Batista RL; Nishi MY; de Paula LCP; Costa EC; Costa EMF; Cukier P; Onuchic LF; Mendonca BB; Domenice S
Sex Dev; 2022; 16(1):46-54. PubMed ID: 34392242
[TBL] [Abstract][Full Text] [Related]
5. A recurrent p.Arg92Trp variant in steroidogenic factor-1 (NR5A1) can act as a molecular switch in human sex development.
Bashamboo A; Donohoue PA; Vilain E; Rojo S; Calvel P; Seneviratne SN; Buonocore F; Barseghyan H; Bingham N; Rosenfeld JA; Mulukutla SN; Jain M; Burrage L; Dhar S; Balasubramanyam A; Lee B; ; Dumargne MC; Eozenou C; Suntharalingham JP; de Silva K; Lin L; Bignon-Topalovic J; Poulat F; Lagos CF; McElreavey K; Achermann JC
Hum Mol Genet; 2016 Aug; 25(16):3446-3453. PubMed ID: 27378692
[TBL] [Abstract][Full Text] [Related]
6. Loss of Function of the Nuclear Receptor NR2F2, Encoding COUP-TF2, Causes Testis Development and Cardiac Defects in 46,XX Children.
Bashamboo A; Eozenou C; Jorgensen A; Bignon-Topalovic J; Siffroi JP; Hyon C; Tar A; Nagy P; Sólyom J; Halász Z; Paye-Jaouen A; Lambert S; Rodriguez-Buritica D; Bertalan R; Martinerie L; Rajpert-De Meyts E; Achermann JC; McElreavey K
Am J Hum Genet; 2018 Mar; 102(3):487-493. PubMed ID: 29478779
[TBL] [Abstract][Full Text] [Related]
7. Sex reversal in C57BL/6J XY mice caused by increased expression of ovarian genes and insufficient activation of the testis determining pathway.
Correa SM; Washburn LL; Kahlon RS; Musson MC; Bouma GJ; Eicher EM; Albrecht KH
PLoS Genet; 2012; 8(4):e1002569. PubMed ID: 22496664
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic Variation in 46,XX Disorders of Sex Development due to the Fourth Zinc Finger Domain Variant of WT1: A Familial Case Report.
Kirino S; Yogi A; Adachi E; Nakatani H; Gau M; Iemura R; Yamano H; Kanamori T; Mori T; Sohara E; Uchida S; Okamoto K; Udagawa T; Takasawa K; Morio T; Kashimada K
Sex Dev; 2023; 17(1):51-55. PubMed ID: 36796343
[TBL] [Abstract][Full Text] [Related]
9. SRY-negative 46,XX testicular/ovotesticular DSD: Long-term outcomes and early blockade of gonadotropic axis.
Lambert S; Peycelon M; Samara-Boustani D; Hyon C; Dumeige L; Peuchmaur M; Fiot E; Léger J; Simon D; Paye-Jaouen A; Bouligand J; Siffroi JP; Carel JC; McElreavey K; El Ghoneimi A; Brachet C; Bouvattier C; Martinerie L
Clin Endocrinol (Oxf); 2021 Apr; 94(4):667-676. PubMed ID: 33296530
[TBL] [Abstract][Full Text] [Related]
10. Duplication of SOX9 is not a common cause of 46,XX testicular or 46,XX ovotesticular DSD.
Seeherunvong T; Ukarapong S; McElreavey K; Berkovitz GD; Perera EM
J Pediatr Endocrinol Metab; 2012; 25(1-2):121-3. PubMed ID: 22570960
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile during testicular development in patients with SRY-negative 46,XX testicular disorder of sex development.
Mizuno K; Kojima Y; Kamisawa H; Moritoki Y; Nishio H; Kohri K; Hayashi Y
Urology; 2013 Dec; 82(6):1453.e1-7. PubMed ID: 24149105
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Wilms' tumor suppressor gene (WT1) in patients 46,XY disorders of sex development.
Köhler B; Biebermann H; Friedsam V; Gellermann J; Maier RF; Pohl M; Wieacker P; Hiort O; Grüters A; Krude H
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1131-6. PubMed ID: 21508141
[TBL] [Abstract][Full Text] [Related]
13. Wt1 negatively regulates beta-catenin signaling during testis development.
Chang H; Gao F; Guillou F; Taketo MM; Huff V; Behringer RR
Development; 2008 May; 135(10):1875-85. PubMed ID: 18403409
[TBL] [Abstract][Full Text] [Related]
14. Are NR5A1 Variations a Frequent Cause of 46,XX Ovotesticular Disorders of Sex Development? Analysis from a Single Center and Systematic Review.
Barros BA; Guaragna MS; Fabbri-Scallet H; Palandi de Mello M; Guerra-Júnior G; Maciel-Guerra AT
Sex Dev; 2022; 16(4):242-251. PubMed ID: 36657429
[TBL] [Abstract][Full Text] [Related]
15. Testicular differentiation in 46,XX DSD: an overview of genetic causes.
Ferrari MTM; Silva ESDN; Nishi MY; Batista RL; Mendonca BB; Domenice S
Front Endocrinol (Lausanne); 2024; 15():1385901. PubMed ID: 38721146
[TBL] [Abstract][Full Text] [Related]
16. The
Gregoire EP; De Cian MC; Migale R; Perea-Gomez A; Schaub S; Bellido-Carreras N; Stévant I; Mayère C; Neirijnck Y; Loubat A; Rivaud P; Sopena ML; Lachambre S; Linssen MM; Hohenstein P; Lovell-Badge R; Nef S; Chalmel F; Schedl A; Chaboissier MC
Science; 2023 Nov; 382(6670):600-606. PubMed ID: 37917714
[TBL] [Abstract][Full Text] [Related]
17. A cell-autonomous role for WT1 in regulating Sry in vivo.
Bradford ST; Wilhelm D; Bandiera R; Vidal V; Schedl A; Koopman P
Hum Mol Genet; 2009 Sep; 18(18):3429-38. PubMed ID: 19549635
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1.
Matsuzawa-Watanabe Y; Inoue J; Semba K
Oncogene; 2003 Sep; 22(39):7900-4. PubMed ID: 12970737
[TBL] [Abstract][Full Text] [Related]
19. Gonadal Identity in the Absence of Pro-Testis Factor SOX9 and Pro-Ovary Factor Beta-Catenin in Mice.
Nicol B; Yao HH
Biol Reprod; 2015 Aug; 93(2):35. PubMed ID: 26108792
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
